Skip to main content
. 2018 Aug 1;9(10):1241–1248. doi: 10.1111/1759-7714.12822

Figure 1.

Figure 1

(a) The progression‐free survival curves at six months and one year were 62.7 and 41.7 for patients treated with microwave ablation (MWA) and 66.0 and 51.3% for patients treated with radiofrequency ablation (RFA), respectively. (b) The overall survival curves at six months, one and two‐years were 90, 76.9, and 55.7 for patients treated with MWA and 88.4, 80.5 and 67.0% for patients treated with RFA, respectively.